RxElite, Inc.
RXEI
$0.00
$0.000.00%
OTC PK
| 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | |
|---|---|---|---|---|---|
| Net Income | -71.62% | 9.24% | -45.46% | -53.01% | 54.52% |
| Total Depreciation and Amortization | 26.09% | 19.82% | 97.39% | 97.92% | 192.93% |
| Total Amortization of Deferred Charges | 8.16% | -13.81% | -- | -- | -- |
| Total Other Non-Cash Items | 204.96% | -31.37% | 96.69% | 895.61% | -96.52% |
| Change in Net Operating Assets | 73.37% | 1,442.94% | -101.39% | 175.28% | -2,572.08% |
| Cash from Operations | 35.83% | 16.62% | -332.77% | 110.73% | -219.05% |
| Capital Expenditure | -163.05% | 102.38% | -484.46% | -634.26% | 129.30% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 200.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -129.24% | 105.00% | -500.58% | -634.26% | 129.30% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -30.32% | -32.72% | -3.13% | 88.92% | -703.88% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | 233.23% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 77.69% | -2,271.32% |
| Cash from Financing | -104.52% | 3,925.07% | -100.76% | 27.93% | 165.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -183.02% | 117.42% | -192.98% | 115,548.81% | 102.71% |